Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Quality of Life of Prostate Cancer Survivors With Androgen Deficiency

NCT03716739 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.

NCT NCT03716739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03716739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Quality of Life of Prostate Cancer Survivors With Androgen Deficiency
Lead sponsor
Dana-Farber Cancer Institute
Phase
Phase 2
Overall status
Completed
Start date
March 19, 2019
Completion date
July 16, 2025
Enrollment
136 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer